<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="24961">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01778114</url>
  </required_header>
  <id_info>
    <org_study_id>H-26117</org_study_id>
    <nct_id>NCT01778114</nct_id>
  </id_info>
  <brief_title>Availability of Vitamin D in Orange Juice</brief_title>
  <official_title>Bioavailability of Vitamin D2 and Vitamin D3 in Supplements Compared to Vitamin D3 and Vitamin D2 in Fortified Orange Juice</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Medical Center</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to determine whether vitamin D2 and vitamin D3 in orange juice
      are effective at raising vitamin D levels in the blood and if vitamin D2 and vitamin D3 in
      orange juice raised blood levels of 25(OH)D as well as vitamin D3 and vitamin D2
      supplements.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study should provide valuable information about the bioavailability of both vitamin D2
      and vitamin D3 formulated in orange juice compared to vitamin D2 and vitamin D3 formulated
      in a pill and taken with water.  It is anticipated based on our previous observation that
      the vitamin D2  and vitamin D3 in orange juice will be at least 50% more effective in
      raising the blood levels of 25(OH)D than when taken in pill form.

      This study will evaluate the bioavailability and metabolism of vitamin D2 and vitamin D3 in
      combination in tablet form. The results should provide important information as to whether a
      physiologic dose of vitamin D2 has a negative effect on circulating levels of
      25-hydroxyvitamin D2  [25(OH)D2 ] and on 25-hydroxyvitamin D3  [25(OH)D3].  Results from
      this study have important implications for expanding the adequate intake (AI)
      recommendations for vitamin D2 and vitamin D3 for adults.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">June 2007</completion_date>
  <primary_completion_date type="Actual">June 2007</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor)</study_design>
  <primary_outcome>
    <measure>Measurement of 25(OH)D levels after ingestion of 1,000 IU of vitamin D2 or vitamin D3 in a capsule</measure>
    <time_frame>11 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measurement 25(OH)D levels after taking vitamin D2 or vitamin D3 in orange juice</measure>
    <time_frame>11 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Compare 25(OH)D levels in subjects taking vitamin D2 versus vitamin D3</measure>
    <time_frame>11 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>It is debated in the literature that vitamin D2 is more effective than vitamin D3 in maintaining 25(OH)D levels in the blood. This outcome measure will help determine if this is true or if they are equally effective.</description>
  </other_outcome>
  <other_outcome>
    <measure>Determine serum 1,25(OH)2D levels</measure>
    <time_frame>11 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">86</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>Placebo + orange juice without vitamin D</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo + orange juice without vitamin D</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo + 1000 IU vitamin D3 in OJ</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin D3 in orange juice</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo + 1000 IU vitamin D2 in OJ</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin D2 in orange juice</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1000 IU vitamin D3 + placebo OJ</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1000 IU vitamin D3 + placebo OJ</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1000 IU vitamin D2 + placebo OJ</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1000 IU vitamin D2 + placebo OJ</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D2 in orange juice</intervention_name>
    <description>1000 IU dose</description>
    <arm_group_label>Placebo + 1000 IU vitamin D2 in OJ</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D3 in orange juice</intervention_name>
    <description>1000 IU</description>
    <arm_group_label>Placebo + 1000 IU vitamin D3 in OJ</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D2</intervention_name>
    <description>capsule, 1000 IU</description>
    <arm_group_label>1000 IU vitamin D2 + placebo OJ</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D3</intervention_name>
    <description>capsule, 1000 IU</description>
    <arm_group_label>1000 IU vitamin D3 + placebo OJ</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Placebo + orange juice without vitamin D</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female adults of all races ages 18 years and older

        Exclusion Criteria:

          -  Pregnant and lactating women

          -  History of chronic severe liver (as defined by liver function test greater than 2
             times upper limit of normal)or kidney disease as defined by a serum creatinine &gt;2.5.

          -  History of taking a daily supplement that contains 400 or more IU vitamin D2 or
             vitamin D3 within the past month or taking a pharmacologic amount of vitamin D2 or
             one of the active vitamin D analogs including Zemplar (Paricalcitol), Dovonex
             (calcipotriol), Hectorol (vitamin D pro hormone)

          -  Subjects who are taking orally Dilantin or glucocorticoids.

          -  Exposure to a tanning bed or tanning on a beach for more than eight hours within the
             past month.

          -  Subjects who drink more than 2 glasses (16 oz) cups of milk a day.

          -  Known history of elevated calcium. (&gt; 10.5 mg% (mg/dl))

          -  History of intestinal malabsorption (i.e. Cystic Fibrosis, Fat malabsorption
             Syndrome, Crohn's Disease)

          -  Allergies to orange juice

          -  Any medical conditions in which it is not advisable to receive one 8 oz. glass of
             orange juice per day.

          -  Currently taking, or having taken less than one month prior to start of study, a
             prescription vitamin D

          -  Unwilling to consent to this trial
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael F Holick, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rachael M Biancuzzo, BS, MA</last_name>
    <role>Study Director</role>
    <affiliation>Boston University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Boston University Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006 Mar;81(3):353-73. Review.</citation>
    <PMID>16529140</PMID>
  </reference>
  <reference>
    <citation>Holick MF. Sunlight &quot;D&quot;ilemma: risk of skin cancer or bone disease and muscle weakness. Lancet. 2001 Jan 6;357(9249):4-6.</citation>
    <PMID>11197362</PMID>
  </reference>
  <reference>
    <citation>Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington (DC): National Academies Press (US); 1997.</citation>
    <PMID>23115811</PMID>
  </reference>
  <reference>
    <citation>Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab. 1988 Aug;67(2):373-8.</citation>
    <PMID>2839537</PMID>
  </reference>
  <reference>
    <citation>Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet. 1998 Mar 14;351(9105):805-6.</citation>
    <PMID>9519960</PMID>
  </reference>
  <reference>
    <citation>Tangpricha V, Koutkia P, Rieke SM, Chen TC, Perez AA, Holick MF. Fortification of orange juice with vitamin D: a novel approach for enhancing vitamin D nutritional health. Am J Clin Nutr. 2003 Jun;77(6):1478-83.</citation>
    <PMID>12791627</PMID>
  </reference>
  <reference>
    <citation>Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT, Petruschke RA, Chen E, de Papp AE. Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab. 2005 Jun;90(6):3215-24. Epub 2005 Mar 29.</citation>
    <PMID>15797954</PMID>
  </reference>
  <reference>
    <citation>Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003 Jan;77(1):204-10. Erratum in: Am J Clin Nutr. 2003 Nov;78(5):1047.</citation>
    <PMID>12499343</PMID>
  </reference>
  <reference>
    <citation>Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004 Nov;89(11):5387-91.</citation>
    <PMID>15531486</PMID>
  </reference>
  <reference>
    <citation>Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr. 1998 Oct;68(4):854-8.</citation>
    <PMID>9771862</PMID>
  </reference>
  <results_reference>
    <citation>Biancuzzo RM, Young A, Bibuld D, Cai MH, Winter MR, Klein EK, Ameri A, Reitz R, Salameh W, Chen TC, Holick MF. Fortification of orange juice with vitamin D(2) or vitamin D(3) is as effective as an oral supplement in maintaining vitamin D status in adults. Am J Clin Nutr. 2010 Jun;91(6):1621-6. doi: 10.3945/ajcn.2009.27972. Epub 2010 Apr 28.</citation>
    <PMID>20427729</PMID>
  </results_reference>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 25, 2013</lastchanged_date>
  <firstreceived_date>January 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Medical Center</investigator_affiliation>
    <investigator_full_name>Michael F. Holick</investigator_full_name>
    <investigator_title>Michael . Holick PhD, MD</investigator_title>
  </responsible_party>
  <keyword>Vitamin D2</keyword>
  <keyword>Vitamin D3</keyword>
  <keyword>Vitamin D</keyword>
  <keyword>Orange Juice</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
